| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $68.4M | +146.3% |
| SG&A Expense | $24.6M | +735.7% |
| Operating Income | -$93.0M | -202.7% |
| Income Tax | $0 | — |
| Net Income | -$84.0M | -111.1% |
| EPS (Basic) | -$3.36 | +79.2% |
| EPS (Diluted) | -$3.36 | +79.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118.3M | -22.1% |
| Short-term Investments | $277.1M | — |
| Current Assets | $398.4M | +162.0% |
| Total Assets | $401.4M | +164.0% |
| Current Liabilities | $20.6M | +106.0% |
| Total Liabilities | $21.5M | +115.3% |
| Stockholders' Equity | $379.9M | +1173.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.8M | -355.1% |
| Capital Expenditures | $167K | — |
| Investing Cash Flow | -$273.9M | — |
| Financing Cash Flow | $315.4M | +87.4% |
| Free Cash Flow | -$74.9M | — |